Home › NDC Lookup › RxCUI directory › RxCUI 2725516

Elinzanetant 60 MG Oral Capsule — RxCUI 2725516

RxNorm drug concept · Semantic clinical drug
RxCUI 2725516 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2725516
Official nameElinzanetant 60 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Elinzanetant: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Lynkuet works differently from hormone therapy. Instead of replacing estrogen, it blocks specific receptors in your brain — called NK1 and NK3 — that are involved in triggering hot...
  • What exactly does Lynkuet do for hot flashes?
  • No — Lynkuet must not be used during pregnancy. Animal studies show it can cause pregnancy loss or stillbirth. Before you start, your doctor will confirm you're not pregnant. If yo...
  • Can I take Lynkuet if I'm still having periods or could get pregnant?
📖 Read our full Elinzanetant guide →

🕸️ Concept Web — How Elinzanetant 60 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Elinzanetant 60 MG Oral Capsule RxCUI 2725516

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Elinzanetant 2725511
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lynkuet 2725517
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Elinzanetant Oral Capsule 2725515
    • Elinzanetant Oral Product 2725513
    • Elinzanetant Pill 2725514
    • Elinzanetant Oral Capsule [Lynkuet] 2725521
    • Lynkuet Oral Product 2725519
    • Lynkuet Pill 2725520
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Elinzanetant 60 MG SCDC · 2725512
  • Elinzanetant Oral Capsule SCDF · 2725515
  • Elinzanetant Oral Product SCDG · 2725513
  • Elinzanetant Pill SCDG · 2725514

Brand-Name Concepts

  • Elinzanetant 60 MG Oral Capsule [Lynkuet] SBD · 2725522
  • Elinzanetant 60 MG [Lynkuet] SBDC · 2725518
  • Elinzanetant Oral Capsule [Lynkuet] SBDF · 2725521
  • Lynkuet Oral Product SBDG · 2725519
  • Lynkuet Pill SBDG · 2725520
  • Lynkuet BN · 2725517

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 2725516 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50419-0475-05 5 BLISTER PACK in 1 CARTON (50419-475-05) / 12 CAPSULE in 1... LYNKUET Bayer HealthCare Pharmaceuticals Inc. 2025-10-24
50419-0475-72 2 BLISTER PACK in 1 CARTON (50419-475-72) / 12 CAPSULE in 1... LYNKUET Bayer HealthCare Pharmaceuticals Inc. 2025-10-24
50419-0475-73 1 BLISTER PACK in 1 CARTON (50419-475-73) / 12 CAPSULE in 1... LYNKUET Bayer HealthCare Pharmaceuticals Inc. 2026-05-07
Observed labelers: Bayer HealthCare Pharmaceuticals Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$10.0008
Range $10.0008–$10.0008 · middle 50% $10.0008–$10.0008 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.